Skip to main content
. 2022 Apr 27;12(6):1142–1165. doi: 10.1002/2211-5463.13416

Fig. 1.

Fig. 1

Influenza replication steps inhibited by influenza antivirals. Schematic representation of the influenza replicative cycle showing the steps inhibited by FDA‐approved influenza antivirals (light blue), antiviral under evaluation in clinical trials (light red), and antivirals under preclinical evaluation (cyan). Figure created with BioRender.com.